About Us
Management Team
Board of Directors
Pipeline
TG-1101 (Ublituximab)
TGR-1202
IRAK4
ANTI-PD-L1 & ANTI-GITR
Publications
Clinical Trials
Investors & Media
Overview
Press Releases
Stock Information
SEC Filings & Financials
Events
IR & Media Contact
Management Team
Corporate Governance
FAQs
Careers
Contact Us
Investors & Media
Overview
Press Releases
Stock Information
Historic Stock Lookup
SEC Filings & Financials
Quarterly Results
Annual Reports
SEC Filings
Events
IR & Media Contact
Management Team
Corporate Governance
FAQs
Events
Second Quarter 2016 Earnings Results
Aug 8, 2016
8:30 AM ET
Listen to webcast
Back to previous page
Shareholder Briefcase
Email Alerts
RSS News Feeds
Print
Email
Share
Share this on:
Delicious
Digg
Facebook
LinkedIn
Twitter
What is this?
Delicious
Digg
Facebook
LinkedIn
Twitter